The CHASIT study was highlighted by UroToday in the section ‘Beyond the Abstract’. In this section, authors can provide additional details on their published abstract or protocol

UroToday is the largest global online community of urologists, GU oncologists, healthcare providers and patients. It delivers credible, timely and accurate urological idsease and treatment information to more than 86,000 readers from 206 countries around the globe. Since 2003, UroToday’s mission is to provide free, accurate, timely, evidence-based genitourinary content to support healthcare providers in their need to stay up-to-date on relevant conditions and to assist pastients in better understanding their treatment and symptoms.

To read the full article, please visit: Sequential Chemo-Immunotherapy in Patients with Locally Advanced Urothelial Cancer – a Non-Randomized Phase II Clinical Trial – Beyond the Abstract (urotoday.com)